Vicki L. Sato, Director: Denali Therapeutics DNLI Sell · Filed 24/03/19

Trade details

Type: Insider sale
Amount: $33,486.6
Shares · price: 1,666 sh · $20.10 a share
Held after: 119,709 sh
Stock: Denali Therapeutics DNLI
Person: Vicki L. SatoDirector
Trade date: 24/03/15
Filed: 24/03/19
Days to filing: 4 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Denali Therapeutics trades, last 26 weeks

What else happened in Denali Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/14~24/04/14

Vicki L. Sato's recent trades

Vicki L. SatoDirector
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$221.1K
22,000 sh
$221.1K
Filed 05/04
Traded 05/01
Vicki L. SatoDirector
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$199.5K
22,000 sh
$199.5K
Filed 04/02
Traded 04/01
Vicki L. SatoDirector
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$207.1K
21,800 sh
$207.1K
Filed 03/03
Traded 03/02
Vicki L. SatoDirector
Sell10b5-1 planVir Biotechnology
Sell10b5-1 plan
Vir Biotechnology
VIR
$1,996
200 sh
$1,996
Filed 03/03
Traded 03/02
Vicki L. SatoDirector
Planned sale10b5-1 planVir Biotechnology
Planned sale10b5-1 plan
Vir Biotechnology
VIR
$799.9K
88,000 sh
$799.9K
Filed 03/02
Traded 03/02

Vicki L. Sato, Director — sold $33.5K of Denali Therapeutics DNLI · 1.4% of holdings · 10b5-1 plan | Whalegun